XORTX Therapeutics Inc. Common Stock — Quarterly Financial Statements (NASDAQ:XRTX) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics

Quarterly Annual

Market Capitalization 2.98 M
Employee 3
Founded 2011
CEO Allen Davidoff
Website www.xortx.com
Headquarter British Columbia, Canada
FIGI BBG00KVK0YG4
Industry Technology

2.98 M Market capitalization

Nouvelles

Pourquoi les actions de Lucas GC se négocient-elles à la hausse de plus de 36% ? Voici 20 actions en mouvement avant l'ouverture du marché | Benzinga France

Why Lucas GC Shares Are Trading Higher By Over 36%; Here Are 20 Stocks Moving Premarket - Alvotech (NASDAQ:ALVO), Apollomics (NASDAQ:APLM)

Pourquoi les actions de Delcath Systems sont en hausse de plus de 14% ; Voici 20 actions qui bougent avant l'ouverture du marché | Benzinga France

Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Beyond Meat (NASDAQ:BYND), Addex Therapeutics (NASDAQ:ADXN)

Morning News Wrap-Up: Friday’s Biggest Stock Market Stories! - TipRanks.com

L’action de XORTX Therapeutics s’envole après l’acquisition d’un programme thérapeutique rénal

XORTX Therapeutics stock soars after acquiring renal therapeutic program

Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket - Apogee Therapeutics (NASDAQ:APGE), Apogee Enterprises (NASDAQ:APOG)

XORTX Therapeutics reports Q1 financials to SEC